martin shkreli

Born: April 1, 1983 (age 33 years), Brooklyn, New York City, NY

Nationality: American

Education: Baruch College (2004)

Nominations: Award for Villain of the Year

Martin Shkreli is an American entrepreneur, CEO and founder of three major companies bringing his estimated net worth to $100 million dollars Shkreli was raised in Brooklyn, the son of Albanian and Croatian immigrants who worked as janitors, according to Bloomberg. Shkreli dropped out of high school and cut his teeth as an intern on Jim Cramer’s CNBC show Mad Money.

Later, Shkreli started a pair of hedge funds, Elea Capital and MSMB Capital.Those endeavors didn’t make him much money, he told the New York Times, but he discovered there was a lot of cash to be made in directly selling pharmaceutical drugs.His pharmaceutical company, Retrophin, sought out old, rarely used drugs and raised their prices—a drug to treat kidney stones, for instance, was raised from $1.50 per pill to $30

In September 2015, Shkreli received widespread criticism when Turing obtained the manufacturing license for the antiparasitic drug Daraprim and raised its price from (from US$13.5 to US$750 per pill), leading him to be referred to by media as "the most hated man in America".

In December 2015, Shkreli was arrested by the FBI after being indicted on federal charges of securities fraud. also known as stock fraud.It is an investment fraud is a deceptive practice in the stock or commodities markets that induces investors to make purchase or sale decisions on the basis of false information, He is free on bail and has a pending trial.

martin shkreli sells the daraprim pills to the government for 1$ but sells them to places like walmart and cvs for 750$ so the people that can't afford the medication can get it for free. Martin is a capitalist but not so much that he has no remorse for human life

Created By
Jesse Gonzales

Made with Adobe Slate

Make your words and images move.

Get Slate

Report Abuse

If you feel that this video content violates the Adobe Terms of Use, you may report this content by filling out this quick form.

To report a Copyright Violation, please follow Section 17 in the Terms of Use.